The Canadian Advanced Therapies Training Institute (CATTI) develops and delivers best-in-class online and onsite training for the ATMP/CGT biomanufacturing sector. CATTI’s mission is to support students and employees with the training and knowledge they require to successfully work under good manufacturing practices (GMP). As a result the future workforce will be qualified to work at the hundreds of jobs being created based on the investment in global life sciences.
CATTI is led by a consortium of two highly successful Networks of Centers of
Excellence in Canada – the Center for the Commercialization of Regenerative Medicine[CCRM] and CellCAN Regenerative Medicine and Cell Therapy Network, which is a knowledge mobilization company. This provides a unique opportunity for CATTI to leverage the strengths and synergies of both organizations to contribute substantially to the growing cell and gene therapy sector in Canada.
CATTI, which was officially incorporated in 2021, has offices in Montreal and Toronto, as well as a practical, CL2 lab-based, training centre for specialized hands-on training at the University of Guelph, about an hour’s drive west of Toronto. This gives CATTI the capacity to focus on providing participants skills development in both GMP and CGT-specific skills in manufacturing stem cells, T-cells, MSCs and viral vector production. Participants will undergo skills verifications through program assessments and online examination to ensure competency requirements have been met.